Loading...
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
Immunotherapy has recently emerged as a novel strategy for treating different types of solid tumors, with promising results. However, still a large fraction of patients do not primarily respond to such approaches, and even responders sooner or later develop resistance. Moreover, immunotherapy is a p...
Saved in:
| Published in: | J Clin Med |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7141336/ https://ncbi.nlm.nih.gov/pubmed/32138216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9030675 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|